GPhA Proposes Pool of Real-Time Data to Fight Shortages
By Mari Serebrov
Monday, August 13, 2012
Hoping to make shortages of critical drugs more the exception than the rule, the generic drug industry is diving into an initiative to give the FDA access to timely manufacturing data.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.